BioSpace News Archive

The Consultants will comply with all applicable securities laws, including the policies of the CSE in providing their services to the Company.

The study challenged mice with MCAo-induced stroke (middle carotid artery occlusion induced stoke) and after four weeks, the number of surviving neurons was quantified and the locomotor function, behavior, and cognition of the mice were evaluated.

Nanomedic Technologies, a leader in Electrospun Healing Fiber (EHF™) technology for wound healing and skin regeneration, today announced that Rambam Health Care Campus, the primary hospital for northern Israel, has selected the Spincare Wound Care System to enhance patient care and improve its ability to heal wounds and burns

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company today is providing shareholders with an update on its pipeline of novel therapeutics targeting dermatological, COVID-19 and support care indications.

Dyadic International, Inc. (“Dyadic”) (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs, and improve the performance of vaccines, drugs and other biological products at flexible commercial scales, today announced a fully funded collaboration with TurtleTree Scientific

B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced its Infusomat® Space® Large Volume Pump was awarded a 2021 Best in KLAS for Traditional Smart Pumps.

QurAlis Corporation, a biotech company focused on developing precision medicines for amyotrophic lateral sclerosis and other neurologic diseases, announced the appointments of Hagen Cramer, Ph.D., to the position of Chief Production Officer, and Kevin Leach, Ph.D., to the position of SVP, Translational Science & Portfolio Strategy.

Pharmaceutical and biotechnology companies are making increased investment in research and development activities, which is likely to amplify growth opportunities of the global custom peptide synthesis services market over the period of assessment.

Hypertriglyceridemia is an augmented level of triglycerides, a type of lipid, in the bloodstream. It is a condition that enhances the risk of coronary artery disease in human beings.

Wearable technologies have proven to be innovative solutions for various issues in the healthcare industry. Wearable devices are also used for patient and disease management and can directly impact clinical decision making.